Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

309 questions · 321 findings · 28 reviews · Headline outcomes only

No studies found 45 · 14%GRADE not reported 21 · 6.5%Very low 91 · 28.3%Low 65 · 20.2%Moderate 82 · 25.5%High 17 · 5.3%

CLOZAPINE vs Typical antipsychotics

Relapse · patients with schizophrenia

CLOZAPINE probably leads to lower relapse ‐ short term compared with TYPICAL ANTIPSYCHOTICS ‐ OVERALL (moderate certainty).

4 findings from 1 review
Show 1 more finding

CLOZAPINE vs Typical antipsychotics

Global state: no improvement ‐ medium termAs defined in each study · patients with schizophrenia

CLOZAPINE probably leads to lower global impression: 1. Not clinically improved ‐ short term compared with TYPICAL ANTIPSYCHOTICS (moderate certainty).

3 findings from 1 review

CLOZAPINE vs Typical antipsychotics

Adverse effects 4. Salivation ‐ too much · patients with schizophrenia

CLOZAPINE probably leads to higher adverse effects 4. Salivation ‐ too much compared with TYPICAL ANTIPSYCHOTICS (moderate certainty).

2 findings from 1 review

CLOZAPINE vs Typical antipsychotics

Weight gain · patients with schizophrenia

CLOZAPINE probably leads to higher adverse effects 5. Weight gain compared with TYPICAL ANTIPSYCHOTICS (moderate certainty).

2 findings from 1 review